Intranasal Immunization with Chitosan/pCAGGS-flaA Nanoparticles InhibitsCampylobacter jejuniin a White Leghorn Model

Intranasal Immunization with Chitosan/pCAGGS-flaA Nanoparticles Inhibits Campylobacter jejuni in a White Leghorn Model

Campylobacter jejuni is the most common zoonotic bacterium associated with human diarrhea, and chickens are considered to be one of the most important sources for human infection, with no effective prophylactic treatment available. We describe here a prophylactic strategy using chitosan-DNA intranasal immunization to induce specific immune responses. The chitosan used for intranasal administrat...

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

We have previously shown that a hexavalent group A streptococcal M protein-based vaccine evoked bactericidal antibodies after intramuscular injection. In the present study, we show that the hexavalent vaccine formulated with several different mucosal adjuvants and delivered intranasally induced serum and salivary antibodies that protected mice from intranasal challenge infections with virulent ...

Mice against Intranasal Challenge Group A Streptococcal Vaccines Protects Intranasal Immunization with Multivalent

Immune Responses Intranasal Immunization Promotes Th17

Early access to perches in caged White Leghorn pullets.

Osteoporosis, a progressive decrease in mineralized structural bone, causes 20 to 35% of all mortalities in caged White Leghorn hens. Previous research has focused on manipulating the egg laying environment to improve skeletal health, with little research on the pullet. The objective of the current study was to determine the effect of perch access on pullet health, bone mineralization, muscle d...